A novel approach to overcome hypoxic tumor resistance: Cu-ATSM-guided intensity-modulated radiation therapy.
暂无分享,去创建一个
S Mutic | M J Welch | J F Dempsey | F Dehdashti | M A Mintun | J A Purdy | M. Mintun | J. Dempsey | M. Welch | S. Mutic | J. Purdy | K. Chao | W. Bosch | C. Perez | K. Chao | J. Lewis | F. Dehdashti | C A Perez | J S Lewis | W R Bosch | K S Chao
[1] P. Wingo,et al. Cancer statistics, 1997 , 1997, CA: a cancer journal for clinicians.
[2] P Vaupel,et al. Association between tumor hypoxia and malignant progression in advanced cancer of the uterine cervix. , 1996, Cancer research.
[3] S. Webb. Optimization by simulated annealing of three-dimensional conformal treatment planning for radiation fields defined by a multileaf collimator. , 1991, Physics in medicine and biology.
[4] D. Low,et al. Quality assurance of serial tomotherapy for head and neck patient treatments. , 1998, International journal of radiation oncology, biology, physics.
[5] U. Mazzi,et al. Technetium and rhenium in chemistry and nuclear medicine , 1990 .
[6] C. Perez,et al. Intensity-modulated radiotherapy (IMRT) with concurrent cisplatin chemotherapy (CT) yields superior therapeutic outcome than conventional techniques with or without chemotherapy in locally advanced nasopharyngeal carcinoma , 2000 .
[7] T K Lewellen,et al. Quantifying regional hypoxia in human tumors with positron emission tomography of [18F]fluoromisonidazole: a pretherapy study of 37 patients. , 1996, International journal of radiation oncology, biology, physics.
[8] Janice M. Y. Brown,et al. The hypoxic cell: a target for selective cancer therapy--eighteenth Bruce F. Cain Memorial Award lecture. , 1999, Cancer research.
[9] J. Tsai,et al. Dosimetric verification of the dynamic intensity-modulated radiation therapy of 92 patients. , 1998, International journal of radiation oncology, biology, physics.
[10] H D Suit,et al. Impact of improved local control on survival. , 1986, International journal of radiation oncology, biology, physics.
[11] C C Ling,et al. Towards multidimensional radiotherapy (MD-CRT): biological imaging and biological conformality. , 2000, International journal of radiation oncology, biology, physics.
[12] S. Webb. Optimization by simulated annealing of three-dimensional, conformal treatment planning for radiation fields defined by a multileaf collimator: II. Inclusion of two-dimensional modulation of the x-ray intensity. , 1992, Physics in medicine and biology.
[13] C B Begg,et al. The effect of local control on metastatic dissemination in carcinoma of the prostate: long-term results in patients treated with 125I implantation. , 1991, International journal of radiation oncology, biology, physics.
[14] Y. Yonekura,et al. Differential mechanism of retention of Cu-pyruvaldehyde-bis(N4-methylthiosemicarbazone) (Cu-PTSM) by brain and tumor: A novel radiopharmaceutical for positron emission tomography imaging , 1995 .
[15] P Vaupel,et al. Oxygenation of human tumors: evaluation of tissue oxygen distribution in breast cancers by computerized O2 tension measurements. , 1991, Cancer research.
[16] A L Boyer,et al. Modulated beam conformal therapy for head and neck tumors. , 1997, International journal of radiation oncology, biology, physics.
[17] P. Cutler,et al. High purity production and potential applications of copper-60 and copper-61. , 1999, Nuclear medicine and biology.
[18] D A Jaffray,et al. Managing geometric uncertainty in conformal intensity-modulated radiation therapy. , 1999, Seminars in radiation oncology.
[19] L. H. Gray,et al. The Histological Structure of Some Human Lung Cancers and the Possible Implications for Radiotherapy , 1955, British Journal of Cancer.
[20] Y Yonekura,et al. Copper-62-ATSM: a new hypoxia imaging agent with high membrane permeability and low redox potential. , 1997, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[21] S. Spencer,et al. Concurrent tirapazamine and radiotherapy for advanced head and neck carcinomas: a Phase II study. , 1998, International journal of radiation oncology, biology, physics.
[22] R Mohan,et al. Clinically relevant optimization of 3-D conformal treatments. , 1992, Medical physics.
[23] M. Dewhirst,et al. Oxygenation of head and neck cancer: changes during radiotherapy and impact on treatment outcome. , 1999, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[24] D Verellen,et al. Target localization and treatment verification for intensity modulated conformal radiation therapy of the head and neck region. The AZ-VUB experience. Akademisch Ziekenhuis-Vrije Universiteit Brussel. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[25] Harold O. Wyckoff,et al. International Commission ON Radiation Units and Measurements (ICRU). , 1974, The American journal of roentgenology, radium therapy, and nuclear medicine.
[26] S A Leibel,et al. The effect of local-regional control on distant metastatic dissemination in carcinoma of the head and neck: results of an analysis from the RTOG head and neck database. , 1991, International journal of radiation oncology, biology, physics.
[27] J. Purdy,et al. Quality assurance for 3D conformal radiation therapy. , 1998, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[28] E. Hall,et al. Radiobiology for the radiologist , 1973 .
[29] S Mutic,et al. Stereotactic imaging quality assurance using an anthropomorphic phantom. , 1999, Computer aided surgery : official journal of the International Society for Computer Aided Surgery.
[30] A. Fyles,et al. Heterogeneity of polarographic oxygen tension measurements in cervix cancer: an evaluation of within and between tumor variability, probe position, and track depth. , 1997, International journal of radiation oncology, biology, physics.
[31] Y. Yonekura,et al. Comparative studies of Cu-64-ATSM and C-11-acetate in an acute myocardial infarction model: ex vivo imaging of hypoxia in rats. , 1999, Nuclear medicine and biology.
[32] A. Rauth,et al. Bioreductive therapies: an overview of drugs and their mechanisms of action. , 1998, International journal of radiation oncology, biology, physics.
[33] D A Low,et al. Intensity‐modulated radiation therapy in head and neck cancers: The Mallinckrodt experience , 2000, International journal of cancer.
[34] Purdy Ja. Advances in three-dimensional treatment planning and conformal dose delivery. , 1997 .
[35] P Vaupel,et al. Oxygenation of human tumors. , 1990, Strahlentherapie und Onkologie : Organ der Deutschen Rontgengesellschaft ... [et al].
[36] M. Dewhirst,et al. Tumor oxygenation predicts for the likelihood of distant metastases in human soft tissue sarcoma. , 1996, Cancer research.
[37] M J Welch,et al. Evaluation of 64Cu-ATSM in vitro and in vivo in a hypoxic tumor model. , 1999, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.
[38] C. Coleman,et al. Phase I trial of the hypoxic cell cytotoxin tirapazamine with concurrent radiation therapy in the treatment of refractory solid tumors. , 1999, International journal of radiation oncology, biology, physics.
[39] S L Meeks,et al. Potential clinical efficacy of intensity-modulated conformal therapy. , 1998, International journal of radiation oncology, biology, physics.
[40] B. Fenton,et al. 31P NMR spectroscopy and HbO2 cryospectrophotometry in prediction of tumor radioresistance caused by hypoxia. , 1989, International journal of radiation oncology, biology, physics.
[41] D. Low,et al. Tumor response and salivary function sparing in patients with oropharyngeal squamous cell carcinoma treated with intensity modulated radiation therapy (IMRT) with/without chemotherapy: the mallinckrodt institute of radiology initial results , 2000 .
[42] D. Verellen,et al. Initial experience with intensity-modulated conformal radiation therapy for treatment of the head and neck region. , 1997, International journal of radiation oncology, biology, physics.
[43] M. Parliament,et al. Measurement of hypoxia in human tumours by non-invasive spect imaging of iodoazomycin arabinoside. , 1996, The British journal of cancer. Supplement.
[44] G. Hanks,et al. Measuring hypoxia and predicting tumor radioresistance with nuclear medicine assays. , 1998, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.
[45] M. Dewhirst,et al. Tumor hypoxia adversely affects the prognosis of carcinoma of the head and neck. , 1997, International journal of radiation oncology, biology, physics.
[46] P. Grigsby,et al. Distant metastases after irradiation alone in carcinoma of the uterine cervix. , 1992, International journal of radiation oncology, biology, physics.
[47] A. Rauth,et al. In vitro and in vivo evaluation of a technetium-99m-labeled 2-nitroimidazole (BMS181321) as a marker of tumor hypoxia. , 1996, Journal of nuclear medicine : official publication, Society of Nuclear Medicine.